Kamada Ltd. (NASDAQ: KMDA)
$5.80
-0.0200 ( -0.34% ) 32.3K
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Market Data
Open
$5.80
Previous close
$5.82
Volume
32.3K
Market cap
$334.53M
Day range
$5.72 - $5.82
52 week range
$4.08 - $6.53
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 50 | May 08, 2024 |
6-k | Quarterly Reports | 2 | May 01, 2024 |
6-k | Quarterly Reports | 16 | Mar 06, 2024 |
20-f | Annual reports | 149 | Mar 06, 2024 |
6-k | Quarterly Reports | 2 | Feb 28, 2024 |
6-k | Quarterly Reports | 1 | Dec 28, 2023 |
6-k | Quarterly Reports | 3 | Dec 06, 2023 |
6-k | Quarterly Reports | 49 | Nov 13, 2023 |
6-k | Quarterly Reports | 3 | Nov 13, 2023 |
6-k/a | Quarterly Reports | 3 | Nov 13, 2023 |